版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
BackgroundCRC:majorcauseofdeathanddiseaseBackgroundProcessesofcolorectalcarcinogenesislendthemselvestoscreeningBackgroundAsubstantialproportionnevertested!ScreeningforCRCiscost-effectiveAsimple,noninvasivetestmightimproveclinicalout-comes28%BackgroundColorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationsAimEvaluatethemultitargetstoolDNAtestasatoolforscreeningAimPrimaryaim:DNAtestinthedetectionofCRCSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)DNAtestVSMethodsStudyPopulation:2011.6-2012.1190sites
AsymptomaticpersonsAgesof50to84ataverageriskforCRCScheduledtoundergoscreeningcolonoscopySecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Asimple,noninvasivetestmightimproveclinicalout-comesAsubstantialproportionnevertested!digestivecancer,orinflammatoryboweldiseasepreviouscolonoscopy,bariumenema,CT,sigmoidoscopyundergonecolorectalresectionAdvancedprecancerouslesions:Advancedadenomashigh-gradedysplasiafamilyhistorySessileserratedpolypsmeasuring1cmormoreindiameterundergonecolorectalresectionStudyPopulation:Agesof50to84ataverageriskforCRCpreviouscolonoscopy,bariumenema,CT,sigmoidoscopyConclusionsSessileserratedpolypsmeasuring1cmormoreindiameterCRC,stagedeterminedwiththeuseoftheAJCCstagingsystempositiveresultsonfecalbloodtesting,rectalbleedingSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)CRC,stagedeterminedwiththeuseoftheAJCCstagingsystemMethodsExcluded
personalhistory:colorectalneoplasia,digestivecancer,orinflammatoryboweldisease
previouscolonoscopy,bariumenema,CT,sigmoidoscopy
positiveresultsonfecalbloodtesting,rectalbleedingundergonecolorectalresectionfamilyhistoryMethodsPrimaryandSecondaryOutcomesCRC,stagedeterminedwiththeuseoftheAJCCstagingsystem
Advancedprecancerouslesions:
Advancedadenomashigh-gradedysplasiawith≥25%villoushistologicfeaturesmeasure≥1cminthegreatestdimension
Sessileserratedpolypsmeasuring1cmormoreindiameteraberrantlymethylatedBMP3andNDRG4promoterregionsmutantKRASimmunochemicalassayforhumanhemoglobinFITMultitargetstoolDNAtestResults127760.7%7.6%ResultsResultsResultsFigure3.ReceiverOperatingCharacteristic(ROC)CurvesComparingDNATestingandFITfortheDetectionofColorectalCancerandAdvancedColorectalNeoplasia.ResultsMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.ConclusionsAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.TranslationalResearchAug.12,2014FDAApprovesCologuardFirstandOnlyStoolDNANoninvasiveColorectalCancerScreeningTestReceivedaproposedcove-ragememorandumfromtheCentersforMedicareandMedicaidServices(CMS)ProcessesofcolorectalcarcinogenesislendthemselvestoscreeningAdvancedprecancerouslesions:CRC,stagedeterminedwiththeuseoftheAJCCstagingsystem1190sitesundergonecolorectalresectionAdvancedprecancerouslesions:familyhistoryAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.positiveresultsonfecalbloodtesting,rectalbleedingpositiveresultsonfecalbloodtesting,rectalbleedingMultitargetstoolDNAtestMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.Aneasy-to-usescreen-ingtestEvaluatethemultitargetstoolDNAtestasatoolforscreeningColorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationsCRC,stagedeterminedwiththeuseoftheAJCCstagingsystempositiveresultsonfecalbloodtesting,rectalbleedingAsymptomaticpersonsAdvancedadenomashigh-gradedysplasiaColorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationsStudyPopulation:PeopleataverageriskforcolorectalcancerAneasy-to-usescreen-ingtest599$BackgroundAsubstantialproportionnevertested!ScreeningforCRCiscost-effectiveAsimple,noninvasivetestmightimproveclinicalout-comes28%MethodsStudyPopulation:2011.6-2012.1190sites
AsymptomaticpersonsAgesof50to84ataverageriskforCRCScheduledtoundergoscreeningcolonoscopyMethodsPrimaryandSecondaryOutcomesCRC,stagedeterminedwiththeuseoftheAJCCstagingsystem
Advancedprecancerouslesions:
Advancedadenomashigh-gradedysplasiawith≥25%villoushistologicfeaturesmeasure≥1cminthegreatestdimension
Sessileserratedpolypsmeasuring1cmormoreindiameterResultsFigure3.ReceiverOperatingCharacteristic(ROC)CurvesComparingDNATestingandFITfortheDetectionofColorectalCancerandAdvancedColorectalNeoplasia.ConclusionsAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.1190sitesAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.CRC,stagedeterminedwiththeuseoftheAJCCstagingsystemAsymptomaticpersonspositiveresultsonfecalbloodtesting,rectalbleedingdigestivecancer,orinflammatoryboweldiseaseAgesof50to84ataverageriskforCRCpreviouscolonoscopy,bariumenema,CT,sigmoidoscopyPrimaryandSecondaryOutcomesmeasure≥1cminthegreatestdimensionAdvancedadenomashigh-gradedysplasiaSessileserratedpolypsmeasuring1cmormoreindiameterCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemFDAApprovesCologuardSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Asimple,noninvasivetestmightimproveclinicalout-comespositiveresultsonfecalbloodtesting,rectalbleedingpositiveresultsonfecalbloodtesting,rectalbleedingPrimaryandSecondaryOutcomesScheduledtoundergoscreeningcolonoscopyAdvancedprecancerouslesions:ReceiverOperatingCharacteristic(ROC)CurvesComparingDNATestingandFITfortheDetectionofColorectalCancerandAdvancedColorectalNeoplasia.undergonecolorectalresectionAdvancedadenomashigh-gradedysplasiaMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.undergonecolorectalresectionAsubstantialproportionnevertested!CRC,stagedeterminedwiththeuseoftheAJCCstagingsystemFDAApprovesCologuardCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemwith≥25%villoushistologicfeaturesCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemFirstandOnlyStoolDNANoninvasiveColorectalCancerScreeningTestSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Sessileserratedpolypsmeasuring1cmormoreindiameterConclusionsdigestivecancer,orinflammatoryboweldiseasepersonalhistory:colorectalneoplasia,Advancedprecancerouslesions:Colorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationspreviouscolonoscopy,bariumenema,CT,sigmoidoscopyPrimaryaim:DNAtestinthedetectionofCRCEvaluatethemultitargetstoolDNAtestasatoolforscreeningCRC,stagedeterminedwiththeuseoftheAJCCstagingsystempreviouscolonoscopy,bariumenema,CT,sigmoidoscopyPrimaryandSecondaryOutcomesAsymptomaticpersonsMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.positiveresultsonfecalbloodtesting,rectalbleedingMultitargetstoolDNAtestpositiveresultsonfecalbloodtesting,rectalbleedingAsymptomaticpersonsfamilyhistoryAsubstantialproportionnevertested!Advancedprecancerouslesions:Processesofcolorectalcarcinogenesislendthemselvestoscreeningpositiveresultsonfecalbloodtesting,rectalbleedingPrimaryandSecondaryOutcomesMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.Advancedprecancerouslesions:Advancedprecancerouslesions:measure≥1cminthegreatestdimensionAdvanc
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 企業(yè)健康管理中的員工視力保健方案
- 體育鍛煉在預(yù)防小學(xué)生慢性病中的作用
- 2024年改性聚苯醚項目提案報告范稿
- 2024年新型聚氨酯漆成膜交聯(lián)劑項目立項申請報告模稿
- 2024年木片、木粒加工產(chǎn)品項目提案報告模板
- 2024年發(fā)動機(jī)用玻璃纖維編織套管項目申請報告
- 景區(qū)安全事故應(yīng)急處理
- 創(chuàng)新型教育環(huán)境下的學(xué)生全面發(fā)展評價體系研究
- 環(huán)保污水處理培訓(xùn)課件
- 體育科技在學(xué)生體能強(qiáng)化中的應(yīng)用前景
- 趣味可拓學(xué)智慧樹知到期末考試答案章節(jié)答案2024年廣東工業(yè)大學(xué)
- (高清版)JTGT 5190-2019 農(nóng)村公路養(yǎng)護(hù)技術(shù)規(guī)范
- 2024年輔警招聘考試試題庫含完整答案(各地真題)
- 體育初中學(xué)生學(xué)情分析總結(jié)報告
- 幕墻工程安裝施工施工管理人員配備及分工
- 國開一體化平臺01588《西方行政學(xué)說》章節(jié)自測(1-23)試題及答案
- 年產(chǎn)5億粒藿香正氣膠囊車間工藝設(shè)計.文檔
- 第17課《昆明的雨》課件(共35張)
- 2023-2024學(xué)年北京市海淀區(qū)七年級(上)期末數(shù)學(xué)試卷(含解析)
- 五官科醫(yī)院感染管理
- 規(guī)劃設(shè)計方案審批全流程
評論
0/150
提交評論